|
Device | PerClot® Polysaccharide Hemostatic System |
Generic Name | Agent, absorbable hemostatic, non-collagen based |
Regulation Number | 878.4490 |
Applicant | Baxter Healthcare Corporation 25212 W. Illinois Route 120 Round Lake, IL 60073 |
PMA Number | P210036 |
Date Received | 10/25/2021 |
Decision Date | 05/19/2023 |
Product Code |
LMG |
Advisory Committee |
General & Plastic Surgery |
Clinical Trials | NCT02359994
|
Expedited Review Granted? | No |
Combination Product | No |
Approval Order Statement Approval for the PerClot® Absorbable Hemostatic Powder. The device is indicated in surgical procedures (except neurological and ophthalmic) as an adjunctive hemostatic device to assist when control of suture line bleeding or capillary, venous and arteriolar bleeding by pressure, ligature, and other conventional procedures is ineffective or impractical. |
Approval Order | Approval Order |
Summary | Summary of Safety and Effectiveness |
Labeling | Labeling
|
Supplements: |
|